Global Bone Regeneration Materials Market to Surpass US$ 2877.0 Mn by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global bone regeneration materials market is estimated to be valued at US$ 2292.1 Mn in 2020 and is expected to exhibit a CAGR of 3.3% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Bone Regeneration Materials Market:

Increasing R&D and innovation in bone regeneration therapy is expected to drive growth of global bone regeneration materials market. For instance, in 2020, the Bone Biologics Corp. Company has bone biologic product named as NELL-1 in its pipeline. The company is developing this product for spinal fusion and also the company expect that this product is used in one regeneration and repair for clinical conditions such as osteoporosis and trauma applications.

Moreover, increasing focus on stem cell research and development is an important factor fueling growth of the global bone regeneration materials market. In the last few years, stem cells have been a used in regenerative medicine due to its capabilities such as self-renewal and differentiation capacity. Additionally, stem cells have properties of secreting bioactive molecules and regulating the behavior of other cells in different host tissues. Stem cells improve bone regeneration process effectively and rapidly. These stem cells are used with scaffolds and growth factors to accelerate bone healing at the site of fracture in a body. Also, stem cells mesenchymal stem cells are used in tissue engineering and have shown progress in different clinical applications as well.

Furthermore, the increasing demand for bone regeneration across the world is expected to drive growth of this market. According to NCBI information, in 2018, the annual cost of treating bone defects was around US$5 billion in the U.S. This costs includes bone grafts for tumors, bone injuries, and other defective fracture healings.

Request Sample Copy of this Report @

Key Market Takeaways:

The global bone regeneration materials market is expected to exhibit a CAGR of XX% during the forecast period (2020-2027), owing to increasing R&D and innovation in the global bone regeneration therapy market.

The growth of the North America global bone regeneration therapy market is attributed to increasing incidence of traumatic injuries in this region. According to the American Association for the Surgery of Trauma Information, in the U.S, around 3 million traumatic injuries accounts for non-fatal injuries and around 150,000 average deaths per year.

Competitive Landscape:

Key players operating in the global bone regeneration materials market are Sigma Graft, NovaBone, B&B Dental, Stryker Corporation, J Morita USA, Kerr Restoratives, Septodont, Citagenix and Ethoss Regeneration Ltd.

Buy-Now this Research Report @

Market Segmentation:

  • Global bone regeneration materials market, By Product Type:

  • Global bone regeneration materials market, By Application:

    • Orthopaedic Surgery

    • Bone Trauma

    • Dental Surgery

    • Others

  • Global bone regeneration materials market, By Region:

    • North America

    • Europe

      • U.K.

      • Germany

      • Italy

      • Spain

      • France

      • Russia

      • Rest of Europe

    • Asia Pacific

      • Australia

      • India

      • China

      • Japan

      • ASEAN

      • South Korea

      • Rest of Asia Pacific

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Report:

Europe Allogeneic Human Chondrocyte Market, By Application (Osteoarthritis, Musculoskeletal System Disorders, and Others), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and By Country (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more:

Epigenetics Drugs & Diagnostic Technologies Market, By Type (Epigenetic Drugs (DNMT Inhibitors (Azacitidine, Decitabine), HDAC Inhibitors (Vorinostat, Romidepsin)), Epigenetics Diagnostic Technologies (DNA Methylation, ChIP Technology)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more:

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on


Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Follow Us: LinkedIn | Twitter

Source Article